Why UnitedHealth Group Stock Lost 17% in December

Shares of UnitedHealth Group (NYSE: UNH) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx.Other media reports also shone a harsh light on the business and could lead to more regulation or an overhaul of some healthcare industry practices.According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see from the chart, the stock fell in three stages over the first half of December, and then traded sideways for the rest of the month.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool